Researcher.Life Logo

Neurology and Therapy : Impact Factor & More

eISSN: 2193-6536pISSN: 2193-8253
JournalOpen Access

Key Metrics

CiteScore
5.3
Eigenfactor
0.001 - 0.005
H-Index
29
Impact Factor
< 5
SJR
Q2Neurology
SNIP
1.21
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Neurology and Therapy

Neurology and Therapy Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher SPRINGER LONDON LTD
Language English
Frequency Semi-annual
Article Processing ChargesEUR 5500 | USD 6850 | GBP 4700
Publication Time6
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencySemi-annual
Publication Start Year2012
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 6
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY-NC
OA statementVisit website
View less

Planning to publish in Neurology and Therapy ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Neurology and Therapy

Impact of Early Intervention on Motor Milestone Achievement in Spinal Muscular Atrophy: Insights from Cure SMA Survey Data.
  • 27 Apr 2026
  • Neurology and therapy
Treatment Characteristics and Healthcare Resource Utilization Among Patients with Myasthenia Gravis Initiating Rozanolixizumab: A US Claims Database Analysis.
  • 27 Apr 2026
  • Neurology and therapy
Real-World Treatment Adherence and Persistence with C5 Inhibitor Therapy Versus Satralizumab in Patients with Neuromyelitis Optica Spectrum Disorder in Japan.
  • 25 Apr 2026
  • Neurology and therapy
Burden Among Caregivers of Adult Patients with Neurofibromatosis Type 1 and Plexiform Neurofibroma in the United States: A Cross-Sectional Survey Study.
  • 17 Apr 2026
  • Neurology and therapy
The Impact of Transcranial Direct Stimulation Therapy Combined with Intranasal Near-Infrared Stimulation on Cognitive Performance in Patients with Mild Cognitive Impairment and Alzheimer's Disease: A Pilot Randomized, Double-Blind, Placebo-Controlled Study.
  • 17 Apr 2026
  • Neurology and therapy
Health-Economic Implications of Post-Stroke Dysphagia: A Contemporary Medicare Claims Analysis.
  • 13 Apr 2026
  • Neurology and therapy
Impact of Early Intervention on Motor Milestone Achievement in Spinal Muscular Atrophy: Insights from Cure SMA Survey Data.
  • 27 Apr 2026
  • Neurology and therapy
Treatment Characteristics and Healthcare Resource Utilization Among Patients with Myasthenia Gravis Initiating Rozanolixizumab: A US Claims Database Analysis.
  • 27 Apr 2026
  • Neurology and therapy
Real-World Treatment Adherence and Persistence with C5 Inhibitor Therapy Versus Satralizumab in Patients with Neuromyelitis Optica Spectrum Disorder in Japan.
  • 25 Apr 2026
  • Neurology and therapy
Burden Among Caregivers of Adult Patients with Neurofibromatosis Type 1 and Plexiform Neurofibroma in the United States: A Cross-Sectional Survey Study.
  • 17 Apr 2026
  • Neurology and therapy
The Impact of Transcranial Direct Stimulation Therapy Combined with Intranasal Near-Infrared Stimulation on Cognitive Performance in Patients with Mild Cognitive Impairment and Alzheimer's Disease: A Pilot Randomized, Double-Blind, Placebo-Controlled Study.
  • 17 Apr 2026
  • Neurology and therapy
Health-Economic Implications of Post-Stroke Dysphagia: A Contemporary Medicare Claims Analysis.
  • 13 Apr 2026
  • Neurology and therapy

FAQs on Neurology and Therapy